Novartis’ FCPA Settlement and New Compliance Guidance

In late June, the DOJ and SEC announced that pharma company Novartis AG and its former subsidiary Alcon Pte Ltd had agreed to pay a combined $347 million to resolve allegations that they engaged in conspiracies to bribe public hospitals and clinics in Greece, Vietnam, and South Korea, much of it to increase prescriptions and […]
Must be a Paid Member or a Free Trial Member to Access Content. Members log in here.